ResMed Equity Investments increased by 6.7% to $163.74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $146.41M to $163.74M. Over 4 years (FY 2021 to FY 2025), Equity Investments shows an upward trend with a 21.9% CAGR.
other_equity_investments_488476| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.24M | $80.07M | $68.60M | $68.50M | $58.38M | $57.36M | $134.78M | $150.45M | $146.54M | $143.66M | $148.70M | $164.03M | $151.23M | $151.29M | $146.97M | $146.41M | $152.90M | $150.14M | $153.47M | $163.74M |
| QoQ Change | — | +15.6% | -14.3% | -0.1% | -14.8% | -1.7% | +135.0% | +11.6% | -2.6% | -2.0% | +3.5% | +10.3% | -7.8% | +0.0% | -2.9% | -0.4% | +4.4% | -1.8% | +2.2% | +6.7% |
| YoY Change | — | — | — | — | -15.7% | -28.4% | +96.5% | +119.6% | +151.0% | +150.5% | +10.3% | +9.0% | +3.2% | +5.3% | -1.2% | -10.7% | +1.1% | -0.8% | +4.4% | +11.8% |